mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.005 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.006 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |